Hbm Holdings Ltd (2142)

Hong Kong
Currency in HKD
4.23
+0.07(+1.68%)
Closed
2142 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Trading near 52-week High
Fair Value
Day's Range
4.074.47
52 wk Range
1.014.47
Key Statistics
Edit
Bid/Ask
4.21 / 4.23
Prev. Close
4.23
Open
4.16
Day's Range
4.07-4.47
52 wk Range
1.01-4.47
Volume
8.31M
Average Volume (3m)
4.34M
1-Year Change
160%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2142 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory
Show more

Hbm Company Profile

HBM Holdings Limited, a clinical-stage biopharmaceutical company, engages in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. The company has developed the Harbour Mice Platform, which generates fully human monoclonal antibodies in the classical two heavy and two light chain H2L2 and heavy chain formats. It is developing Batoclimab (HBM9161), a human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor; HBM7008, a bispecific antibody targeting tumor Associated antigen; HBM4003, a human anti-CTLA-4 antibody against cytotoxic T-lymphocyte-associated antigen-4; and HBM1020, human monoclonal antibody generated from harbour mice platform targeting B7H7. The company is also developing HBM9378 for the treatment of Asthma; and HBM1007, HBM1022, HBM7022, HBM9027, HBM9033, HBM7004, HBM1047, and HBM9014 for the treatment of solid tumors. It operates in Mainland China, the United States, Europe, and internationally. The company has collaborations with AstraZeneca, Pfizer, Hualan Genetic Engineering Co., Ltd., Beigene, Ltd., Duality Biotherapetuics, Inc., Mythic Therapeutics, Washington University, Evive Biotech. HBM Holdings Limited was incorporated in 2016 and is based in Suzhou, the People’s Republic of China.

Employees
182
Market
Hong Kong

Compare 2142 to Peers and Sector

Metrics to compare
2142
Peers
Sector
Relationship
P/E Ratio
18.4x−2.7x−0.6x
PEG Ratio
0.14−0.170.00
Price/Book
3.2x1.4x2.6x
Price / LTM Sales
5.4x8.0x3.1x
Upside (Analyst Target)
-76.7%51.7%
Fair Value Upside
Unlock8.5%7.5%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Hbm (2142) Stock Price Today?

The Hbm stock price today is 4.23.

What Stock Exchange Does Hbm Trade On?

Hbm is listed and trades on the Hong Kong stock exchange.

What Is the Stock Symbol for Hbm?

The stock symbol for Hbm is "2142."

What Is the Hbm Market Cap?

As of today, Hbm market cap is 3.10B.

What is Hbm Earnings Per Share?

The Hbm EPS is 0.029.

From a Technical Analysis Perspective, Is 2142 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.